Treatment after 40 isn’t a simple yes-or-no answer. Studies show men in their forties and beyond can still see noticeable regrowth with finasteride, especially on the crown and mid-scalp, and trials of topical minoxidil support this in younger men.
The front hairline may respond less reliably, and regrowth is usually partial. Whether long-term treatment is worth it depends on where you are losing hair, your routine, and how you view the risks of side effects.
Why male pattern baldness keeps progressing in your 40s
Male pattern baldness is an ongoing condition, not a one-time event. Hair follicles gradually shrink and spend less time in the growth phase, making hair at the front, mid-scalp, and crown thinner over time. For many men, the visible change continues well into their forties and beyond.
One Australian study of 1,390 men aged 40 to 69 found crown-area thinning in 31% of men aged 40 to 55 and 53% of men aged 65 to 69, while frontal-only thinning was similar across age groups.1
Doctors often describe this progression with the Norwood scale, a stage-based way to record how far the thinning has advanced. The pattern can continue to progress with age, which is why a scalp exam remains valuable even if the first changes occurred many years ago.
What male pattern baldness treatment can do in your 40s
Treatment in your forties can still increase hair count and slow further thinning. The strongest age-specific evidence in this range comes from oral finasteride, while topical minoxidil and dutasteride have supporting data from somewhat younger trial groups.
The Japanese Dermatological Association’s 2017 guideline lists oral finasteride or dutasteride, topical 5% minoxidil, and hair transplantation as main options.
What studies by age group show
Three sets of trial results are useful for men in their forties, but each has a different study population and follow-up period.
| Study population | What the study reported | How to read it |
|---|---|---|
| Men aged 18 to 60 with crown thinning | Finasteride increased hair in all photographed areas over 24 months compared with placebo. | Older men still gained hair, but hairline improvement was less clear. |
| Men aged 18 to 49 in a topical minoxidil trial | 5% minoxidil produced more regrowth than 2% minoxidil or placebo over 48 weeks. | The trial supports topical minoxidil, but it did not include men aged 50 or older. |
| Men aged 20 to 61 in a 10-year follow-up | Improvement held over time in a small group followed without a control group. | Late improvement is possible, and some men first improved after one year. |
What this means for your expectations
In a 24-month randomized trial, finasteride increased hair in all measured areas compared with placebo, including the crown, mid-scalp, and hairline, among men with crown thinning.2
Researchers then examined age separately and found that the older group showed clear decreases in crown and mid-scalp hair loss, while the hairline improved less clearly than in the younger group.
A small 10-year follow-up of 118 men aged 20 to 61 found that the improvement was maintained over time, though the study had no control group and some men needed about a year before seeing the first change.3
Dutasteride has trial support in men aged 20 to 50, but that evidence came from a shorter 24-week study.
Which thinning areas respond more clearly at this age
Men in their forties should not expect every thinning area to respond equally. The crown and mid-scalp tend to respond most clearly in this age group, while regrowth at the front hairline can be harder to achieve.
In a 24-month trial of men with crown thinning, finasteride increased hair in all four measured areas across the full study group, and men aged 41 to 60 still gained hair. For this older group, however, the trial showed a clear decrease in loss only in the crown and mid-scalp.2
The same study found that sexual side effects were slightly more common with finasteride, but the rate did not differ by age.
That pattern matters because many men first notice a receding front hairline in photos. For men in their forties, early crown thinning may respond better to treatment than a receding hairline. A doctor can identify the stage and pattern before setting expectations.
Side effects and the everyday burden of treatment
The main daily burden is sticking with treatment, not just tolerating side effects. Oral finasteride can cause sexual problems in a small group of men, and those rates do not appear to rise simply because a man is in his forties.
A meta-analysis of 15 double-blind trials involving 4,495 men found that sexual side effects were more common with finasteride or dutasteride than with placebo, although the increase was modest.4
The authors urged doctors to ask about sexual symptoms before treatment and during use. Topical minoxidil can cause scalp itching, redness, or irritation.
Many medication trials evaluate safety for one year or less, and trial volunteers can differ from people prescribed treatment in daily practice. For oral treatment, the decision often comes down to whether a small chance of sexual side effects feels acceptable for the possible benefit.
A doctor can review your health history and check for symptoms that would change the plan.
What to know about a hair transplant
A hair transplant does not stop male pattern baldness, but it can move more resistant hair into areas that have lost coverage. The surgery suits some patterns better than others, and medication is sometimes continued afterward.
- Hair moved from the back of the scalp tends to resist thinning longer.
- A doctor still needs to judge whether your loss pattern, donor area, and goals make transplant a reasonable choice.
- Continuing oral or topical treatment after surgery may help protect the surrounding hair.
The value of a transplant depends on how much stable donor hair you have and how your thinning is likely to progress. A transplant cannot restore a full juvenile hairline for everyone, and it does not prevent future loss around the transplanted area.
How to decide if treatment is worth it
Treatment after 40 is worth considering if you know which area concerns you most and can maintain a daily routine. To decide, weigh the likely response against the time, cost, and side effects.
- Your goal: slow further loss, regrow hair at the crown, or improve the front hairline.
- Where you are losing hair: the crown and mid-scalp generally respond better than the front hairline.
- Your routine: oral treatment requires daily use, and topical treatment usually requires continued application.
- Side effects: decide whether the possible sexual or scalp side effects of your chosen treatment feel acceptable.
A scalp exam can show how far your hair loss has progressed and whether medication, a transplant, or watchful waiting makes sense now. If you are weighing these options, our doctor will examine your scalp at our clinics in Tokyo and Yokohama and talk through your choices.
Frequently asked questions
- Is it too late to treat male pattern baldness in my 40s?
-
No, it is not too late. Men in their forties can still regrow some hair and slow further loss, especially at the crown and mid-scalp, though regrowth is usually partial.
- Does treatment work as well in my 40s as in younger men?
-
The clearest difference is at the front hairline. Trials show older men can still gain hair, but hairline improvement is less consistent than improvement at the crown and mid-scalp.
- Are the side effects worse after 40?
-
Available trial data do not show that sexual side effects increase with age. The main concern is evaluating your own health history and whether you can accept the small chance of side effects.
- Should I consider a hair transplant instead of medication?
-
A transplant can move resistant hair into thinning areas, but it does not stop future thinning around the transplant. Many men combine surgery with ongoing medication, and a doctor should judge whether your pattern is suitable.
References
1. Severi, G., Sinclair, R., Hopper, J. L., English, D. R., McCredie, M. R., Boyle, P., & Giles, G. G. (2003). Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. The British Journal of Dermatology, 149(6), 1207-13. https://doi.org/10.1111/j.1365-2133.2003.05565.x
2. Olsen, E. A., Whiting, D. A., Savin, R., Rodgers, A., Johnson-Levonas, A. O., Round, E., Rotonda, J., Kaufman, K. D., & Male Pattern Hair Loss Study Group (2012). Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo. Journal of the American Academy of Dermatology, 67(3), 379-86. https://doi.org/10.1016/j.jaad.2011.10.027
3. Rossi, A., Cantisani, C., Scarnò, M., Trucchia, A., Fortuna, M. C., & Calvieri, S. (2011). Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up. Dermatologic Therapy, 24(4), 455-61. https://doi.org/10.1111/j.1529-8019.2011.01441.x
4. Lee, S., Lee, Y. B., Choe, S. J., & Lee, W. S. (2019). Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Acta Dermato-venereologica, 99(1), 12-17. https://doi.org/10.2340/00015555-3035
Manabe, M., Tsuboi, R., Itami, S., Osada, S. I., Amoh, Y., Ito, T., Inui, S., Ueki, R., Ohyama, M., Kurata, S., Kono, T., Saito, N., Sato, A., Shimomura, Y., Nakamura, M., Narusawa, H., Yamazaki, M., & Drafting Committee for the Guidelines for the Diagnosis and Treatment of Male- and Female-Pattern Hair Loss (2018). Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. The Journal of Dermatology, 45(9), 1031-1043. https://doi.org/10.1111/1346-8138.14470
Belknap, S. M., Aslam, I., Kiguradze, T., Temps, W. H., Yarnold, P. R., Cashy, J., Brannigan, R. E., Micali, G., Nardone, B., & West, D. P. (2015). Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis. JAMA Dermatology, 151(6), 600-6. https://doi.org/10.1001/jamadermatol.2015.36
Liu, Y., Tosti, A., Wang, E. C. E., Heilmann-Heimbach, S., Aguh, C., Jimenez, F., Lin, S. J., Kwon, O., & Plikus, M. V. (2025). Androgenetic alopecia. Nature Reviews. Disease Primers, 11(1), 73. https://doi.org/10.1038/s41572-025-00656-9
Norwood, O. T. (1975). Male pattern baldness: classification and incidence. Southern Medical Journal, 68(11), 1359-65. https://doi.org/10.1097/00007611-197511000-00009





